The Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients in a Primary Medical Center in Jordan

Pharmacist-Patient Relations Clinical Trial

Official title:

A Randomized Controlled Trial to Assess the Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients for Optimum Treatment Outcomes in a Primary Medical Center in Jordan

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06029842
• Other study ID #: Clinical pharmacist
• Status: Completed
• Phase: N/A
• Start date: October 17, 2022
• Est. completion date: April 24, 2023

Study information

• Verified date: December 2023
• Source: University of Jordan
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aimed to assess the impact of the clinical pharmacist on enhancing type 2 diabetic patients outcomes in a primary health care center.

Description:

About 103 patients with type 2 diabetes were randomized to control or intervention group, the control group received a standard care, while the intervention group received the collaborative care between the clinical pharmacist and physicians. Fasting blood glucose, HbA1c, Lipid profile, and blood pressure measured for both groups at baseline and after three months of follow-up. Treatment related problems (TRPs), quality of life, adherence, and patients knowledge about their medications were assessed. Cost avoidance and clinical significance of implemented clinical pharmacist interventions were assessed too.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 103
• Est. completion date: April 24, 2023
• Est. primary completion date: April 24, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• type 2 diabetic patients who aged 18 years or more with a HbA1c reading 6.5 % or more at the time of diagnosis

Exclusion Criteria:

• pregnant patients

• breastfeeding patients

• patients with urgent or emergent cases

• patients with cognitive impairment

• if the patient is unable to provide informed written consent

Related Conditions & MeSH terms

• Pharmacist-Patient Relations

Intervention

Other:
• Collaborative approach of clinical pharmacist with physicians in a medical center
For those who allocated to the intervention group, the clinical pharmacist interviewed them at each monthly visit about 30 minutes before seeing physicians, the clinical pharmacist identified treatment related problems, provided medication counseling, answered questions asked by patients or physicians, encouraged compliance, offered instructions on self-monitoring of blood pressure and glucose levels, distributed educational materials about diabetes and emphasis was made on optimizing adherence to pharmacological and non- pharmacological therapy. the pharmacist interventions on treatment related problems (TRPs) and proposed patient care plans were discussed with treatng physicians who decided to accept or reject them.

Locations

Country	Name	City	State
Jordan	Abu-Nsair medical center	Amman

Sponsors (1)

Lead Sponsor	Collaborator
University of Jordan

Country where clinical trial is conducted

Jordan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	HbA1c		3 months
Secondary	Lipid profile	LDL , HDL , TGS	3 months
Secondary	Fasting blood glucose		each month for 3 months
Secondary	blood pressure		3 months